Prot #A4091059: A Phase 3, Randomized, Double Blind, Placebo and Active Controlled, Multicenter, Parallel Group Study of the Analgesic Efficacy and Safety of Tanezumab in Adult Subjects with Chronic Low Back Pain

Project: Research project

Project Details

StatusActive
Effective start/end date9/11/159/11/21

Funding

  • INC Research, LLC (Prot #A4091059)
  • Pfizer Inc. (Prot #A4091059)